MedTrace Logo

The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients

NCT06903546 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2025-04-03

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if propolis administration works to change the level of Low Density Lipoprotein (LDL) and High Density Lipoprotein cholesterol (HDL) in diabetic type 2 patients.

The main questions it aims to answer are:

\- Is giving 1 drops/ 10kg/ times, twice daily for 8 weeks will change the level of LDL and HDL level in diabetic type 2 patients compared to placebo? Researchers will compare propolis to a placebo (a look-alike substance that contains no drug) to see if propolis works to change LDL and HDL cholesterol level.

Participants will:

* Take propolis or a placebo, 2 times daily with given dose (1 drops/10 kg/times) every day for 2 months
* Visit the sub-district health centre once every 2 weeks for checkups
* Get their blood checked before and after intervention

Conditions

  • Diabetes Mellitus Type 2

Interventions

DRUG

Propolis drops

The intervention given is propolis drops that are approved by Indonesian Food and Drug Authority

OTHER

Placebo

The given placebo are look-alike substance with no effect

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • Dwirini R Gunarti, Biomed Science · Indonesia University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-18
Primary Completion
2025-06-30
Completion
2025-07-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06903546 on ClinicalTrials.gov